Follow-up study on participants who previously participated in IERP2007-009 (Myopia progression in children: multifocal soft contact lenses versus single vision soft contact lenses) to determine their current ocular refractive status and collect questionnaire data.

Brien Holden Vision Institute0 个研究点目标入组 26 人开始时间: 2012年1月23日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•have successfully enrolled in study IERP2007-009
•be able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent (or their parent(s)/legal guardian);
•if under 18 years of age, be accompanied by their parent(s)/legal guardian when signing the informed consent form;
•be willing to comply with the clinical trial visit schedule as directed by the investigator;
•have ocular health findings considered to be normal”;

•Any pre-existing ocular irritation, injury or condition (including infection or disease) of the cornea, conjunctiva or eyelids that would preclude the use of diagnostic eye drops (1% tropicamide and 0.4% oxybuprocaine).
•a need for concurrent category S3 and above ocular medication up to 12 weeks prior to and during the trial;
•any systemic disease that may affect ocular health. Conditions such as systemic hypertension do not automatically exclude prospective participants;
•any systemic or topical medications up to 12 weeks prior to and during the trial that will affect ocular physiology;
•had eye surgery within 12 weeks immediately prior to enrolment for this trial;
•known allergy or intolerance to ingredients in any of the clinical trial products

发起方

Brien Holden Vision Institute